During the past decade, National Cancer Institute - Bratislava conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Cancer Institute - Bratislava" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 20 trials, followed by "National Cancer Institute, Slovakia" with 7 trials sponsored, "Central European Cooperative Oncology Group" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Cancer Institute - Bratislava" #1 collaborator was "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Anticancer Fund, Belgium" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Australia and New Zealand Sarcoma Association" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "National Cancer Institute - Bratislava" are "Sarcoma" (5 trials), "Lymphoma" (4 trials), "Cancer" (3 trials), "Germ Cell Tumor" (3 trials) and "Leukemia" (3 trials). Many other conditions were trialed in "National Cancer Institute - Bratislava" in a lesser frequency.

Most popular intervention types in "National Cancer Institute - Bratislava" are "Drug" (35 trials), "Biological" (11 trials), "Procedure" (8 trials), "Radiation" (5 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (5 trials), "doxorubicin hydrochloride" (5 trials), "ifosfamide" (5 trials), "bleomycin sulfate" (4 trials) and "filgrastim" (4 trials). Other intervention names were less common.

The vast majority of trials in "National Cancer Institute - Bratislava" are 29 trials for "All" genders, 7 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "National Cancer Institute - Bratislava". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in National Cancer Institute - Bratislava, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in National Cancer Institute - Bratislava, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".